Bluebook
Diagnostics and Tools March 2024
2024 - March: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Invicro, LLC was acquired by Calyx Services Inc.
- Telix Pharmaceuticals Limited (ASX:TLX) announced its acquisition of ARTMS, INC.
- Zephyr AI, Inc. closed a $111.4MM Series A Financing, led by Eli Lilly and, Revolution Growth, EPIQ Capital Group, LLC